While this may be true to some extent, chronic lipopolysaccharide administration in AD animals lacking 5LO increases steady-state levels of γ-secretase machinery and tau phosphorylation but does not change baseline microgliosis, astrocytosis, or brain levels of inflammatory cytokines (Joshi et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.